A new study from the PARADIGM-HF and PARAGON-HF clinical trials found that sacubitril/valsartan significantly reduced the ...

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

If you're on a drug for high blood pressure or heart failure, it's pretty likely that you're doing your best to keep your ...

Medicare Part D provides coverage for Entresto. Learn more about Medicare drug coverage and the costs of Entresto.

Even trace amounts of impurities in medication can spell trouble. Yet, recent research shows that nearly one-third of ...

Diastolic blood pressure is the number at the bottom of a blood pressure reading. For example, a standard blood pressure is ...

Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure ...

Hopital National Ignace Deen, Conakry, Guinea. 3 Hopital de L’amitié Sino-Guineenne, Conakry, Guinea. Despite current ...

Pay a tax of up to 1,900% (not 95%) on the total sales revenue of the medicine selected for price setting. News coverage ...

The "Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Training Course" conference has been added to ResearchAndMarkets.com's offering. Cognitive assessment has long ...

Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation ...